Search hospitals > Michigan > Novi
Henry Ford Medical Center-Columbus
Claim this profileNovi, Michigan 48377
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
139 reported clinical trials
5 medical researchers
Summary
Henry Ford Medical Center-Columbus is a medical facility located in Novi, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Henry Ford Medical Center-Columbus is involved with conducting 139 clinical trials across 321 conditions. There are 5 research doctors associated with this hospital, such as Ding Wang, Haythem Y. Ali, Eleanor M. Walker, and Stuart Gordon.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Ding WangHenry Ford Hospital5 years of reported clinical research
Expert in Cancer
Studies Non-Small Cell Lung Cancer
49 reported clinical trials
116 drugs studied
Haythem Y. AliHenry Ford Hospital5 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
38 reported clinical trials
102 drugs studied
Eleanor M. WalkerHenry Ford Hospital2 years of reported clinical research
Studies Cancer
Studies Oral Squamous Cell Carcinoma
18 reported clinical trials
58 drugs studied
Stuart GordonHenry Ford Health System2 years of reported clinical research
Studies Liver Cirrhosis
Studies Cholangitis
13 reported clinical trials
16 drugs studied
Clinical Trials running at Henry Ford Medical Center-Columbus
Non-Small Cell Lung Cancer
Bladder Cancer
Bladder Carcinoma
Lung Cancer
Squamous Cell Carcinoma
Cancer
Renal Cell Carcinoma
Breast Cancer
Urothelial Carcinoma
Prostate Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This study is evaluating whether the addition of a drug to chemotherapy may help treat non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This study is evaluating whether a drug called crizotinib may help treat patients with non-small cell lung cancer.
Recruiting2 awards Phase 328 criteria
PF-07799933
for Advanced Cancers
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07799933) administered as a single agent and in combination with other study medicines (called binimetinib) in people with solid tumors. This study is seeking participants who have an advanced solid tumor with a certain type of abnormal gene called "BRAF" and available treatments are no longer effective in controlling their cancer. All participants in this study will receive PF-07799933. PF-07799933 comes as a tablet to take by mouth, 2 times a day. Depending on the part of the study, participants may also receive another study medicine: People with melanoma or other solid tumors may also receive binimetinib. Binimetinib comes as a tablet to take by mouth, 2 times a day. People with colorectal cancer may also receive cetuximab. Cetuximab will be given weekly (or every two weeks) in the clinic as a shot given in the vein or port (intravenous, IV). Participants may receive the study medicines for about 2 years. The study team will monitor how each participant is doing with the study treatment during regular visits at the study clinic.
Recruiting1 award Phase 14 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Henry Ford Medical Center-Columbus?
Henry Ford Medical Center-Columbus is a medical facility located in Novi, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence and other specialties. Henry Ford Medical Center-Columbus is involved with conducting 139 clinical trials across 321 conditions. There are 5 research doctors associated with this hospital, such as Ding Wang, Haythem Y. Ali, Eleanor M. Walker, and Stuart Gordon.